p-(4-ETHYLPHENYLAZO)-N-METHYLANILINE

Suppliers

Names

[ CAS No. ]:
55398-27-1

[ Name ]:
p-(4-ETHYLPHENYLAZO)-N-METHYLANILINE

[Synonym ]:
Benzenamine,4-((4-ethylphenyl)azo)-N-methyl
p-(4-Ethylphenylazo)-N-methylaniline
4'-Ethyl-N-methyl-4-aminoazobenzene
ANILINE,p-(4-ETHYLPHENYLAZO)-N-METHYL
N-Methyl-4'-ethyl-p-aminoazobenzene

Chemical & Physical Properties

[ Density]:
1.04g/cm3

[ Boiling Point ]:
404.3ºC at 760 mmHg

[ Molecular Formula ]:
C15H17N3

[ Molecular Weight ]:
239.31600

[ Flash Point ]:
198.3ºC

[ Exact Mass ]:
239.14200

[ PSA ]:
36.75000

[ LogP ]:
4.77910

[ Index of Refraction ]:
1.57

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
BY0800000
CHEMICAL NAME :
Aniline, p-(4-ethylphenylazo)-N-methyl-
CAS REGISTRY NUMBER :
55398-27-1
LAST UPDATED :
198910
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C15-H17-N3
MOLECULAR WEIGHT :
239.35
WISWESSER LINE NOTATION :
2R DNUNR DM1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1890 mg/kg/15W-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Liver - tumors
REFERENCE :
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. Volume(issue)/page/year: 15,67,1954
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
181 mg/kg/8W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Tumorigenic - tumors at site of application
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year: 35,880,1975

Related Compounds

  • p-(4-n-propylcyclohexyl)-p'-ethylbiphenyl
  • 4'-ethyl-4-(4-n-pentyl-cyclohexyl)biphenyl
  • p-(4-trans-n-Pentylcyclohexyl)benzoic acid
  • p-hydroxybenzoquinone-4-(N-methyl)pyridone
  • p-Heptylacetophenone
  • p-heptylbenzenethiol
  • 6-(Methoxycarbonyl)-4-(trifluoromethyl)pyridine-2-carboxylic acid
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • N1-(3-(2,5-dimethylfuran-3-yl)-3-hydroxypropyl)-N2-(1-isobutyryl-1,2,3,4-tetrahydroquinolin-7-yl)oxalamide
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine